Published in Vision Res on May 24, 2006
Axonal sodium-channel bands shape the response to electric stimulation in retinal ganglion cells. J Neurophysiol (2009) 1.83
Factors Affecting Perceptual Threshold in Argus II Retinal Prosthesis Subjects. Transl Vis Sci Technol (2013) 1.26
Loss of responses to visual but not electrical stimulation in ganglion cells of rats with severe photoreceptor degeneration. J Neurophysiol (2009) 1.25
An in vitro model of a retinal prosthesis. IEEE Trans Biomed Eng (2008) 1.20
Inner and outer retinal mechanisms engaged by epiretinal stimulation in normal and rd mice. Vis Neurosci (2011) 0.94
Focal electrical stimulation of major ganglion cell types in the primate retina for the design of visual prostheses. J Neurosci (2013) 0.90
Undersized dendritic arborizations in retinal ganglion cells of the rd1 mutant mouse: a paradigm of early onset photoreceptor degeneration. J Comp Neurol (2012) 0.89
A novel in vitro sensing configuration for retinal physiology analysis of a sub-retinal prosthesis. Sensors (Basel) (2012) 0.85
Local signaling from a retinal prosthetic in a rodent retinitis pigmentosa model in vivo. J Neural Eng (2014) 0.83
A high-density microelectrode-tissue-microelectrode sandwich platform for application of retinal circuit study. Biomed Eng Online (2015) 0.80
Aberrant Activity in Degenerated Retinas Revealed by Electrical Imaging. Front Cell Neurosci (2016) 0.76
Electronic approaches to restoration of sight. Rep Prog Phys (2016) 0.75
Initial experience using the transconjunctival sutureless vitrectomy system for vitreoretinal surgery. Ophthalmology (2002) 5.10
PMN-PT single crystal, high-frequency ultrasonic needle transducers for pulsed-wave Doppler application. IEEE Trans Ultrason Ferroelectr Freq Control (2007) 4.16
A new 25-gauge instrument system for transconjunctival sutureless vitrectomy surgery. Ophthalmology (2002) 4.10
Visual perception in a blind subject with a chronic microelectronic retinal prosthesis. Vision Res (2003) 3.78
Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products. J Immunol Methods (2004) 3.53
Outcomes of 140 consecutive cases of 25-gauge transconjunctival surgery for posterior segment disease. Ophthalmology (2005) 2.85
Twelve-month safety of intravitreal injections of bevacizumab (Avastin): results of the Pan-American Collaborative Retina Study Group (PACORES). Graefes Arch Clin Exp Ophthalmol (2007) 2.51
Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the Pan-American Collaborative Retina Study Group at 6-month follow-up. Ophthalmology (2007) 2.38
Characterization of birdshot chorioretinopathy using extramacular enhanced depth optical coherence tomography. JAMA Ophthalmol (2013) 2.36
The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology (2013) 2.35
Signal strength is an important determinant of accuracy of nerve fiber layer thickness measurement by optical coherence tomography. J Glaucoma (2009) 2.19
Feasibility study of a retinal prosthesis: spatial vision with a 16-electrode implant. Arch Ophthalmol (2009) 1.96
Factors associated with variability in retinal nerve fiber layer thickness measurements obtained by optical coherence tomography. Ophthalmology (2007) 1.91
Visual performance using a retinal prosthesis in three subjects with retinitis pigmentosa. Am J Ophthalmol (2007) 1.88
Retinal prosthesis. Annu Rev Biomed Eng (2005) 1.84
Artificial vision: needs, functioning, and testing of a retinal electronic prosthesis. Prog Brain Res (2009) 1.74
Retinal prostheses: current clinical results and future needs. Ophthalmology (2011) 1.70
Area of peripheral retinal nonperfusion and treatment response in branch and central retinal vein occlusion. Retina (2014) 1.70
Acute macular neuroretinopathy: long-term insights revealed by multimodal imaging. Retina (2012) 1.68
In vitro electrical properties for iridium oxide versus titanium nitride stimulating electrodes. IEEE Trans Biomed Eng (2002) 1.63
The long-term natural history of geographic atrophy from age-related macular degeneration: enlargement of atrophy and implications for interventional clinical trials. Ophthalmology (2007) 1.63
Ability of new vital dyes to stain intraocular membranes and tissues in ocular surgery. Am J Ophthalmol (2009) 1.59
Factors affecting perceptual thresholds in epiretinal prostheses. Invest Ophthalmol Vis Sci (2008) 1.55
Perceptual thresholds and electrode impedance in three retinal prosthesis subjects. IEEE Trans Neural Syst Rehabil Eng (2005) 1.52
Primary intravitreal bevacizumab for the management of pseudophakic cystoid macular edema: pilot study of the Pan-American Collaborative Retina Study Group. J Cataract Refract Surg (2007) 1.51
Evaluation of age-related macular degeneration with optical coherence tomography. Surv Ophthalmol (2012) 1.47
Retinal prosthesis for the blind. Surv Ophthalmol (2002) 1.43
Effect of oxygenated intraocular irrigation solutions on the electroretinogram after vitrectomy. Retina (2007) 1.43
Patient selection for macular translocation surgery using the scanning laser ophthalmoscope. Ophthalmology (2002) 1.41
A novel method to oxygenate intraocular irrigation fluids with an in-line oxygenator. Retina (2007) 1.39
SD OCT features of dry arcuate longstanding retinal folds. Eur J Ophthalmol (2011) 1.38
Primary intravitreal bevacizumab for diffuse diabetic macular edema: the Pan-American Collaborative Retina Study Group at 24 months. Ophthalmology (2009) 1.38
Relationship between optical coherence tomography retinal parameters and visual acuity in diabetic macular edema. Ophthalmology (2010) 1.38
Evaluation of optical coherence tomography retinal thickness parameters for use in clinical trials for neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci (2009) 1.36
Cytokines in neovascular age-related macular degeneration: fundamentals of targeted combination therapy. Br J Ophthalmol (2011) 1.33
Quantitative subanalysis of optical coherence tomography after treatment with ranibizumab for neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci (2008) 1.33
Subretinal implantation of retinal pigment epithelial cells derived from human embryonic stem cells: improved survival when implanted as a monolayer. Invest Ophthalmol Vis Sci (2013) 1.30
Spatial distribution of posterior pole choroidal thickness by spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci (2011) 1.28
Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis. Am J Ophthalmol (2004) 1.26
Relationship among visual field, blood flow, and neural structure measurements in glaucoma. Invest Ophthalmol Vis Sci (2012) 1.25
Weight gain measured at 6 weeks after birth as a predictor for severe retinopathy of prematurity: study with 317 very low birth weight preterm babies. Graefes Arch Clin Exp Ophthalmol (2008) 1.22
Predicting visual sensitivity in retinal prosthesis patients. Invest Ophthalmol Vis Sci (2008) 1.21
Characteristics of visual loss by scanning laser ophthalmoscope microperimetry in eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration. Am J Ophthalmol (2003) 1.21
An in vitro model of a retinal prosthesis. IEEE Trans Biomed Eng (2008) 1.20
Investigation of the retinal biocompatibility of acid violet for chromovitrectomy. Graefes Arch Clin Exp Ophthalmol (2013) 1.20
Ranibizumab inhibits multiple forms of biologically active vascular endothelial growth factor in vitro and in vivo. Exp Eye Res (2007) 1.19
Visual and electrical evoked response recorded from subdural electrodes implanted above the visual cortex in normal dogs under two methods of anesthesia. J Neurosci Methods (2003) 1.18
Endophthalmitis after pars plana vitrectomy: results of the Pan American Collaborative Retina Study Group. Retina (2011) 1.17
Relationship between optical coherence tomography retinal parameters and visual acuity in neovascular age-related macular degeneration. Ophthalmology (2008) 1.15
In vitro and in vivo evaluation of ultrananocrystalline diamond for coating of implantable retinal microchips. J Biomed Mater Res B Appl Biomater (2006) 1.15
Comparison of clinically relevant findings from high-speed fourier-domain and conventional time-domain optical coherence tomography. Am J Ophthalmol (2009) 1.15
Intravitreal bevacizumab for refractory pseudophakic cystoid macular edema: the Pan-American Collaborative Retina Study Group results. Ophthalmology (2009) 1.15
Effects on the contralateral eye after intravitreal bevacizumab and ranibizumab injections: a case report. Ann Acad Med Singapore (2008) 1.15
Performance analysis of new-generation vitreous cutters. Graefes Arch Clin Exp Ophthalmol (2007) 1.13
Effects of subretinal injections of indocyanine green, trypan blue, and glucose in rabbit eyes. Ophthalmology (2007) 1.13
A therapeutic anti-VEGF antibody with increased potency independent of pharmacokinetic half-life. Cancer Res (2010) 1.10
Retinal and optic nerve diseases. Artif Organs (2003) 1.10
A novel approach for subretinal implantation of ultrathin substrates containing stem cell-derived retinal pigment epithelium monolayer. Ophthalmic Res (2012) 1.10
Visually guided performance of simple tasks using simulated prosthetic vision. Artif Organs (2003) 1.09
Effects of indocyanine green injection on the retinal surface and into the subretinal space in rabbits. Retina (2004) 1.09
Brightness as a function of current amplitude in human retinal electrical stimulation. Invest Ophthalmol Vis Sci (2009) 1.07
Fluidics in a dual pneumatic ultra high-speed vitreous cutter system. Ophthalmologica (2012) 1.07
Measurements of attenuation coefficient for evaluating the hardness of a cataract lens by a high-frequency ultrasonic needle transducer. Phys Med Biol (2009) 1.06
Dyes in ocular surgery: principles for use in chromovitrectomy. Am J Ophthalmol (2009) 1.06
Peripheral autofluorescence and clinical findings in neovascular and non-neovascular age-related macular degeneration. Ophthalmology (2013) 1.04
Ligand binding assays in the 21st century laboratory: recommendations for characterization and supply of critical reagents. AAPS J (2012) 1.04
Quantitative optical coherence tomography findings in various subtypes of neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci (2008) 1.04
Frequency and amplitude modulation have different effects on the percepts elicited by retinal stimulation. Invest Ophthalmol Vis Sci (2012) 1.03
Effects of intravitreal indocyanine green injection in rabbits. Retina (2004) 1.03
Imaging the response of the retina to electrical stimulation with genetically encoded calcium indicators. J Neurophysiol (2013) 1.03
Retinal vein cannulation with prolonged infusion of tissue plasminogen activator (t-PA) for the treatment of experimental retinal vein occlusion in dogs. Am J Ophthalmol (2004) 1.02
Long-term stimulation by active epiretinal implants in normal and RCD1 dogs. J Neural Eng (2005) 1.02
Ultra-wide-field green-light (532-nm) autofluorescence imaging in chronic Vogt-Koyanagi-Harada disease. Ophthalmic Surg Lasers Imaging (2011) 1.01
Virtual vitreoretinal surgical simulator as a training tool. Retina (2004) 1.01
The effects of intravitreous bevacizumab on retinal neovascular membrane and normal capillaries in rabbits. Invest Ophthalmol Vis Sci (2007) 1.01
Evaluation of lens hardness in cataract surgery using high-frequency ultrasonic parameters in vitro. Ultrasound Med Biol (2007) 1.01
Resolution of the epiretinal prosthesis is not limited by electrode size. IEEE Trans Neural Syst Rehabil Eng (2011) 1.01
Type 3 neovascularization: evolution, association with pigment epithelial detachment, and treatment response as revealed by spectral domain optical coherence tomography. Retina (2015) 1.01
Retinal transplants restore visual responses: trans-synaptic tracing from visually responsive sites labels transplant neurons. Eur J Neurosci (2008) 1.01